AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2020

Mar 13, 2020

33090_dirs_2020-03-13_0c385208-e956-4be1-bec6-abbd96522d4b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2020-03-11

Reporting Person: FEBBO WILLIAM J (Director, CHIEF EXECUTIVE OFFICER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-11	Unvested Restricted Stock Award	$	A	84746	Acquired	2020-12-31	12/31/20 (84746)	Direct

Footnotes

F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020.